Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Magnera Corp. R (W2B.F)

Compare
15.40
-1.20
(-7.23%)
At close: April 4 at 8:11:21 AM GMT+2
Loading Chart for W2B.F
  • Previous Close 16.60
  • Open 15.40
  • Bid 13.60 x --
  • Ask 13.70 x --
  • Day's Range 15.40 - 15.40
  • 52 Week Range 14.94 - 21.84
  • Volume 31
  • Avg. Volume 10
  • Market Cap (intraday) 545.16M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -18.36
  • Earnings Date Feb 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 30, 2022
  • 1y Target Est --

Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, personal care, and infection prevention. It primarily manufactures a range of products and components of healthcare and hygiene products, including baby diapers, medical garments, wipes, dryer sheets, face masks, and filtration. The company also manufactures a collection of healthcare, hygiene, and industrial products and components of products, including baby diapers, medical garments, wipes, face masks, corrosion protection, cable wrap and filtration. The company is headquartered in Charlotte, North Carolina.

magnera.com

--

Full Time Employees

September 28

Fiscal Year Ends

Recent News: W2B.F

View More

Performance Overview: W2B.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

W2B.F
24.21%
S&P 500 (^GSPC)
13.73%

1-Year Return

W2B.F
30.07%
S&P 500 (^GSPC)
1.42%

3-Year Return

W2B.F
89.38%
S&P 500 (^GSPC)
10.72%

5-Year Return

W2B.F
88.67%
S&P 500 (^GSPC)
103.89%

Compare To: W2B.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: W2B.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    479.57M

  • Enterprise Value

    2.14B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    1.81

  • Enterprise Value/EBITDA

    35.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.69%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.37B

  • Net Income Avi to Common (ttm)

    -206M

  • Diluted EPS (ttm)

    -18.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    215M

  • Total Debt/Equity (mrq)

    187.25%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: W2B.F

View More

Company Insights: W2B.F

Research Reports: W2B.F

View More